Venoarterial extracorporeal life support (VA-ECLS) is a lifesaving circulatory support in hemodynamic collapse induced by miscellaneous etiologies. However, survival rates vary among etiologies. To investigate the therapeutic effectiveness of VA-ECLS in hemodynamic collapse induced by fulminant @entity296 ( @entity296 ), a retrospective chart review of 14 @entity1 was conducted, among the 294 adults receiving VA-ECLS in a single institution from April 2006 to April 2013. All @entity1 received echocardiography, coronary angiography, or computed tomography before or immediately after undergoing VA-ECLS to exclude anatomic @entity299 . @entity2401 (n = 12) and peripartum @entity296 (n = 2) were the subcategories of fulminant @entity296 . The median door-to-ECLS duration was 12 hours. Seven @entity1 received cardiopulmonary resuscitation (CPR) before VA-ECLS, and three required ECLS-assisted CPR to regain circulation. Two @entity1 were transplanted as a result of myocardial irreversibility and one survived. Nine of the nontransplant @entity1 survived after a median VA-ECLS of 167 hours. All of the 10 survivors, including the five experiencing dialysis-dependent @entity810 , had their cardiac and renal function return to normal within 6 months after the episode. The VA-ECLS was a practical therapeutic option in fulminant @entity296 . It could provide expeditious hemodynamic support and preserve organ viability essential to recovery.

Extracorporeal life support in adults with hemodynamic collapse from fulminant XXXX : the chance of bridging to recovery.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity296 :: ('MESH:D009202', 'Disease') :: ['cardiomyopathy', 'CM'] @entity810 :: ('MESH:D058186', 'Disease') :: ['acute renal failure'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac diseases'] @entity2401 :: ('MESH:D009205', 'Disease') :: ['Myocarditis']
@entity296 :: (MESH:D009202,Disease) :: ['cardiomyopathies']
